Validation and application of a high-performance liquid chromatography–tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid–liquid extraction
Introduction
Kaletra is a co-formulation of lopinavir and ritonavir. Lopinavir is an inhibitor of HIV protease. As co-formulated in Kaletra, ritonavir inhibits the CYP3A-mediated metabolism of lopinavir, thereby providing increased plasma levels of lopinavir.
Lopinavir is chemically designed as [1S-[1R*), (R*), 3R*, 4R*]]-N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydrox-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide. Its molecular formula is C37H48N4O5, and its molecular weight is 628.80. Fig. 1 shows lopinavir structure.
Ritonavir is chemically designed as 10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-diozo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester [5S-(5R*,10R*,11R*)]. Its molecular formula is C37H48N6O5S2, and its molecular weight is 720.95. Ritonavir has the structural formula in Fig. 1.
Both lopinavir and ritonavir are white to light tan powder. They are freely soluble in methanol and ethanol, soluble in isopropanol and practically insoluble in water.
The combination of lopinavir and ritonavir is used in the treatment of the infection caused by the HIV, which is the virus responsible for acquired immunodeficiency syndrome (AIDS). The combination of lopinavir and ritonavir is used to slow the progression of disease in patients infected with HIV who have advanced symptoms, early symptoms, or no symptoms at all.
Lopinavir and ritonavir will not cure or prevent HIV infection or AIDS; however, it helps to keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delaying the development of problems usually related to AIDS or HIV disease. Lopinavir and ritonavir will not keep HIV affected from spreading HIV to other people. People who receive this medicine may continue to have other problems usually related to AIDS or HIV disease.
The ever-shortening timeline in drug discovery and development have brought about the need for high throughput approaches to methods used to quantitate drugs, metabolites and endogenous biomolecules in biological matrices [1], [2], [3]. A rapid and high-throughput method has been developed and validated to simultaneously determine lopinavir and ritonavir in human plasma using LC/MS/MS.
It is well known that the combination of high-performance liquid chromatography and mass spectrometry (LC–MS) has a significant impact on drug development over the past decade [4]. Continual improvements in LC–MS interface technologies combined with powerful features for structure analysis, qualitative and quantitative, have resulted in a widened scope of application. These improvements coincided with breakthroughs in combinatorial chemistry, molecular biology, and an overall industry trend of accelerated development [5].
Evidently, LC–MS has become widely accepted as an integral part of the drug development process [6]. This paper describes the simultaneous determination of lopinavir and ritonavir in human plasma using LC/MS/MS. A significant part of the method is the ability to employ parallel HPLC separations with detection by a single MS/MS system to provide the sensitivity and selectivity sufficient to achieve robust analytical results, and high throughput. It has been used to successfully support bioavailability, co-administration of a lopinavir/ritonavir tablet formulation with Efavirenz, and pharmacokinetics studies.
Because a dual system setup (two HPLCs with one MS) was used, the throughput was even doubled compared with the traditional LC/MS/MS system (one HPLC with one MS).
Section snippets
Material and reagents
All aqueous solutions including the HPLC mobile phase were prepared with purified deionized water (Milli-Q, Millipore, France). Glacial acetic acid, sodium carbonate, and ammonium acetate were all ACS grade from J.T. Baker (Phillipsburg, NJ, USA). Hexanes, and methyl acetate were HPLC grade from Sigma–Aldrich (St. Louis, MO, USA). Dimethyl sulfoxide (DMSO) was HPLC grade from Aldrich (Milwaukee, WI, USA). Lopinavir, ritonavir, and internal standard (I.S., A-86093) were manufactured and
Results and discussion
This paper describes an analytical method and the validation results for the determination of lopinavir and ritonavir in human plasma using A-86390 as an I.S. A semi-automated liquid–liquid extraction method in 96-well format was used to extract the drug analytes from human plasma samples. An LC/MS/MS method was used to generate the chromatographic peak areas of the analytes and I.S. for quantification.
Since lopinavir has a hydroxyl group and ether bond, and ritonavir has amine groups, both can
Conclusion
A sensitive LC–MS/MS method for simultaneous determination of lopinavir and ritonavir using semi-automatic 96-well liquid–liquid extraction was validated for human plasma. The calibration curves showed goodness of fit over a broad concentration range of 19–5300 ng/mL for lopinavir and 11–3100 ng/mL for ritonavir using a linear regression with 1/x2 weighting. This method has successfully supported clinical pivotal bioequivalence, and bioavailablity studies for Kaletra.
Acknowledgement
The authors greatly appreciate Dr. Raymond Wieboldt for his noble help and encouragements. Dr. Wieboldt passed away in 2003.
References (7)
- et al.
J. Chromatogr. B
(2004) - et al.
Mass Spectrom. Rev.
(2003) Biomed. Chromatogr.
(2000)
Cited by (63)
Influence of traditional Chinese medicines on the in vivo metabolism of lopinavir/ritonavir based on UHPLC-MS/MS analysis
2022, Journal of Pharmaceutical AnalysisCitation Excerpt :Several studies have reported the use of LC-MS/MS to determine the drug concentrations of lopinavir and ritonavir in biological samples after administration. Sample pretreatment methods include liquid-liquid extraction [33], solid phase extraction [34], and alkaline protein precipitation combined with liquid-liquid extraction [31]. In this study, the protein precipitation method, liquid-liquid extraction method (ethyl acetate as extraction solvent), and liquid-liquid extraction after alkaline protein precipitation (NaOH alkalization, ethyl acetate as solvent) were compared.
Modern Sample Preparation for Chromatography
2021, Modern Sample Preparation for ChromatographyAchievements in robotic automation of solvent extraction and related approaches for bioanalysis of pharmaceuticals
2018, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesCitation Excerpt :In their other work, such liquid handler was again used for all liquid transfers and off-line coupled to a dual-HPLC-single-MS system. The method proved to be sensitive, thus plasma volume could be reduced to half (100 μL → 50 μL) [99]. In their several successive works, a high automation level was achieved with this robotic system when linifanib (ABT-869) and its metabolite (ABT-849529) were determined in human plasma or urine.
Thermal stability and hydration behavior of ritonavir sulfate: A vibrational spectroscopic approach
2015, Journal of Pharmaceutical AnalysisDetermination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods
2014, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesCitation Excerpt :Therefore, the quantification of LPV unbound concentrations can be useful in some specific populations and/or conditions. Several methodologies by liquid chromatography (LC) coupled to tandem mass spectrometry (MS/MS) have been published for the simultaneous determination of total concentrations of LPV in plasma, either with other PIs [7–14], or with PIs and non-nucleoside reverse transcriptase inhibitors (NNRTI) [15–24]. Several available data exist for the quantification of LPV in ultrafiltrate [25–28,11,29,30]; however, its methodology has scarcely been full validated.
Development and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir
2014, Journal of Pharmaceutical and Biomedical AnalysisCitation Excerpt :Several HPLC methods were published for the determination of antiretroviral drugs including ritonavir in different formulations [9–11]. A few CE and LC-MS methods were reported for the analysis of ritonavir and its metabolites in biological fluids [12,13]. A micellar electrokinetic chromatography method was also reported for the determination of impurities in ritonavir [14].